Steve M. Sabus

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Diego, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Michael A. Metzger, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Steve M. Sabus

Form 4 holding Chief Commercial Officer

Syndax Pharmaceuticals Inc

Security class
Stock Options (Right to buy)
Shares / value
220,000
Estimated value
$5,685,614
Report date
05 Dec 2022
Price
$25.84
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding SVP & Chief Commercial Officer

Turning Point Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
17 Aug 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Steve M. Sabus

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .